Deep Vein Thrombosis Clinical Trial
Official title:
Influence of Tourniquet Use and Surgery Duration on the Incidence of Deep Vein Thrombosis in Total Knee Arthroplasty
This is an observational study to analyze the influence of surgery duration and tourniquet time in the incidence of deep venous thrombosis (DVT) in patients that had undergone total knee arthroplasty (TKA).
Influence of Tourniquet Use and Surgery Duration on the Incidence of Deep Vein Thrombosis in
Total Knee Arthroplasty
Tourniquet, Surgery Duration and DVT in TKA.
Abstract:
Objective: The occurrence of deep vein thrombosis (DVT) was evaluated in 78 patients
submitted to total knee arthroplasty (TKA), followed by ascending venography (AV), between
the seventh and twelfth days postoperative.
Methods: Patients received prophylaxis with oral anticoagulation for 12 days, maintaining
INR at around 2.5.
Results: Results showed 45 cases (57.7%) of negative bilateral AV and 33 (42.3%) cases of
positivity for DVT. Thirteen cases were of the proximal type DVT, making up 16.7% of the
total. We compared the groups with and without DVT, and another which considered only cases
with proximal DVT.
Conclusion: The statistical analysis didn`t reveal significance in relation to tourniquet
time, despite the higher likelihood of proximal DVT after 90 minutes (p=0.08) and surgery
duration of more than 120 minutes increases its risk.
Keywords: Deep vein thrombosis. Prophylaxis. Thromboembolism. Tourniquet. Knee prosthesis.
Introduction Total knee arthroplasties (TKAs), together with total hip arthroplasties, are
frequently the object of study regarding deep vein thrombosis (DVT) (1); however, DVT also
commonly occurs in other knee procedures (2). Despite the importance of this problem and the
interest in it, most researchers studying DVT generally focus on prophylaxis for prevention;
surprisingly, there have been few studies of the isolated risk factors for DVT associated
with TKA. Although there is some controversy about the role of TKA alone as a risk factor
for DVT (3-7), some researchers believe that bone manipulation, reaming of the medullary
canal, and the duration of the different procedures are relevant risk factors for DVT (8,9).
Another important and controversial factor related to TKA is the use of surgical
tourniquets. Although all these factors are mentioned in the literature, surgery duration as
an isolated risk factor for DVT in TKA has received little attention.
We used ascending venography (AV) to evaluate the association between the use of tourniquets
and total procedure duration and the occurrence of DVT during TKA.
Patients and Methods Seventy-eight consecutive patients from our institution underwent
cemented TKA for degenerative knee disorders and then underwent AV, for which they gave
informed consent, at a point between 7 and 12 days after surgery, after having been
discharged from the hospital. Of the 78, 78.2% were women and 21.8% were men, with an
average age of 65.1 years (range, 31-88 years; SD, 11.5 years). Osteoarthrosis was the
diagnosis in 74.4%, rheumatoid arthritis in 21.8%, and other disorders in 3.8%.
All patients received prophylaxis for DVT with oral anticoagulants for 12 days, with an
international normalized ratio being maintained at about 2.5 (range, 2.0-3.0) in all cases.
Perioperatively, we recorded total pneumatic tourniquet time and total surgery duration, in
minutes. In all cases, the use of a tourniquet was interrupted by hemostasis, after
cementation of the implant and before wound closure. Five categories were established for
total tourniquet time: <60, 61 to 90, 91 to 120, and >120 minutes. The total procedure
duration was defined in the same way; we recorded the times of the initial incision and the
last suture stitch made to close the incision. Three categories were defined for procedure
duration: <120, 121 to 150, and >150 minutes. Only 2 patients (3.1%) were given a general
anesthetic; all the others were given a spinal block.
The study end point was defined as the execution of bilateral AV at a point between 7 and 12
days after surgery, after hospital discharge. The AV was carried out by a specialist in
vascular radiology. The technique applied was basically that described by Rabinov and Paulin
(10). The presence of clinically manifested DVT and/or pulmonary embolism was also taken in
to consideration. The clinical manifestations of DVT were greater edema of the lower limb
than would be expected for the procedure, associated with intense pain on palpation of the
calf and pain on passive dorsiflexion of the foot.
AV findings were considered positive for DVT in the presence of blood clots in the vein
lumens (Figure 1). They were characterized as occurring on the operated side, contralateral
or bilateral, and were diagnosed as proximal DVT (more severe) or distal DVT (less severe),
depending on the contents of the radiologist's report.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05003843 -
BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis
|
N/A | |
Recruiting |
NCT03937947 -
Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
|
||
Withdrawn |
NCT04136561 -
Novel Strategy to Encourage Early Removal of Central Venous Catheters
|
N/A | |
Completed |
NCT03420625 -
Blood Flow Stimulation in the Lower Limbs by Application of Different External Devices
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02555111 -
Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.
|
Phase 3 | |
Completed |
NCT01975090 -
The SENTRY Clinical Study
|
N/A | |
Terminated |
NCT02469376 -
Evaluation of a New Imagingtechnologie for Thrombosis
|
Phase 1 | |
Completed |
NCT02037607 -
Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures
|
N/A | |
Not yet recruiting |
NCT01357941 -
Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
|
N/A | |
Completed |
NCT00771303 -
Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
|
||
Completed |
NCT00720915 -
D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
|
N/A | |
Completed |
NCT00773448 -
Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism
|
N/A | |
Completed |
NCT00244725 -
Odiparcil For The Prevention Of Venous Thromboembolism
|
Phase 2 | |
Completed |
NCT00264277 -
D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism
|
Phase 4 | |
Completed |
NCT00365950 -
3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
|
Phase 4 | |
Completed |
NCT00182403 -
Fixed Dose Heparin Study
|
Phase 3 | |
Completed |
NCT03682419 -
Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL)
|
N/A | |
Not yet recruiting |
NCT04981327 -
The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis
|
Phase 3 | |
Recruiting |
NCT03240120 -
A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
|
Phase 3 |